Process economy of disposable manufacturing -process models to minimize upfront investment

American Pharmaceutical Review

Volumn 10, Issue 5, 2007, Pages

  Lim, Janice A C ^a   Sinclair, Andrew ^a  

^a BioPharma Services   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; WATER;

ARTICLE; CALCULATION; CASE STUDY; COMPARATIVE STUDY; COST; COST BENEFIT ANALYSIS; DRUG MANUFACTURE; ECONOMIC ASPECT; EQUIPMENT; INSURANCE; INVESTMENT; METHODOLOGY; MODEL; TAX;

EID: 47249136971     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hodge, G. Disposable Components Enable a New Approach to Biopharmaceutical Manufacturing. BioProcess Int'l, March 2004.
2. Sinclair, A.; Monge, M. Biomanufacturing for the 21st Century Designing a Concept Facility Based on Single-Use Systems, BioProcess Int'l, October 2004.
3. Sinclair, A.; Monge, M. Concept Facility Based on Single-Use Systems, Part 2 - Leading the Way for Biomanufacturing in the 21st Century, BioProcess Int'l, October 2005.
4. Mora, J.; Sinclair, A.; Delmdahl, N.; Gottschalk, U. Disposable Membrane Chromatography Performance Analysis and Economic Cost Model. BioProcess Int'l, June 2006.
5. Lim, J. A. C.; Sinclair, A.; Kim. D. S.; Gottschalk, U. Economic Benefits of Single-Use Membrane Chromatography in Polishing - ACost of Goods Model, BioProcess Int'l, February 2007.
6. Remer, D. S.; Idrove H. J. Cost Estimating Factors for Biopharmaceutical Process Equipment, Pharm. Technol. Int., March 1991, 36-42.